277 related articles for article (PubMed ID: 7577659)
1. Management of persistent B19 parvovirus infection in AIDS.
Ramratnam B; Gollerkeri A; Schiffman FJ; Rintels P; Flanigan TP
Br J Haematol; 1995 Sep; 91(1):90-2. PubMed ID: 7577659
[TBL] [Abstract][Full Text] [Related]
2. Fifth disease after immunoglobulin administration in an AIDS patient with parvovirus-induced red cell aplasia.
French AL; Sacks L; Schechter GP
Am J Med; 1996 Jul; 101(1):108-9. PubMed ID: 8686703
[No Abstract] [Full Text] [Related]
3. Red cell aplasia caused by parvovirus B19 in AIDS: use of i.v. immunoglobulin.
Koduri PR; Kumapley R; Khokha ND; Patel AR
Ann Hematol; 1997; 75(1-2):67-8. PubMed ID: 9322687
[TBL] [Abstract][Full Text] [Related]
4. Parvovirus B19-induced persistent pure red cell aplasia in a child with T-cell immunodeficiency.
Tavil B; Sanal O; Turul T; Yel L; Gurgey A; Gumruk F
Pediatr Hematol Oncol; 2009 Mar; 26(2):63-8. PubMed ID: 19322736
[TBL] [Abstract][Full Text] [Related]
5. Parvovirus B19-related anemia in HIV-infected patients.
Koduri PR
AIDS Patient Care STDS; 2000 Jan; 14(1):7-11. PubMed ID: 12240888
[TBL] [Abstract][Full Text] [Related]
6. Chronic pure red cell aplasia caused by parvovirus B19 in AIDS: use of intravenous immunoglobulin--a report of eight patients.
Koduri PR; Kumapley R; Valladares J; Teter C
Am J Hematol; 1999 May; 61(1):16-20. PubMed ID: 10331506
[TBL] [Abstract][Full Text] [Related]
7. Acute renal failure in a pediatric kidney allograft recipient treated with intravenous immunoglobulin for parvovirus B19 induced pure red cell aplasia.
Subtirelu MM; Flynn JT; Schechner RS; Pullman JM; Feuerstein D; Del Rio M
Pediatr Transplant; 2005 Dec; 9(6):801-4. PubMed ID: 16269055
[TBL] [Abstract][Full Text] [Related]
8. Parvovirus B19-induced red cell aplasia treated with plasmapheresis and immunoglobulin.
Ramage JK; Hale A; Gane E; Cohen B; Boyle M; Mufti G; Williams R
Lancet; 1994 Mar; 343(8898):667-8. PubMed ID: 7906821
[No Abstract] [Full Text] [Related]
9. Persistent parvovirus B19 infection resulting in red cell aplasia after allogeneic hematopoietic stem cell transplantation.
Koda Y; Mori T; Kato J; Kohashi S; Kikuchi T; Mitsuhashi T; Murata M; Uemura T; Handa M; Okamoto S
Transpl Infect Dis; 2013 Dec; 15(6):E239-42. PubMed ID: 24134728
[TBL] [Abstract][Full Text] [Related]
10. Isolated Anemia in a 69-Year-Old Man with HIV-1: Features of Pure Red Cell Aplasia Mediated by Chronic Parvovirus-B19 Infection.
Wylde J; Berneri MA; Malherbe JAJ; Davel S
Am J Case Rep; 2022 Jul; 23():e936445. PubMed ID: 35871772
[TBL] [Abstract][Full Text] [Related]
11. [Parvovirus B19 infection in HIV-infected patients].
Petrenko AA; Dudina GA; Kremneva NV; Pivnik AV
Ter Arkh; 2020 Sep; 92(7):100-103. PubMed ID: 33346452
[TBL] [Abstract][Full Text] [Related]
12. Persistent parvovirus B19 related anemia of seven years' duration in an HIV-infected patient: complete remission associated with highly active antiretroviral therapy.
Mylonakis E; Dickinson BP; Mileno MD; Flanigan T; Schiffman FJ; Mega A; Rich JD
Am J Hematol; 1999 Feb; 60(2):164-6. PubMed ID: 9929113
[TBL] [Abstract][Full Text] [Related]
13. Pure red cell aplasia due to parvovirus B19 infection in solid organ transplantation.
Ahsan N; Holman MJ; Gocke CD; Groff JA; Yang HC
Clin Transplant; 1997 Aug; 11(4):265-70. PubMed ID: 9267713
[TBL] [Abstract][Full Text] [Related]
14. Parvovirus-B19-associated complications in renal transplant recipients.
Waldman M; Kopp JB
Nat Clin Pract Nephrol; 2007 Oct; 3(10):540-50. PubMed ID: 17895931
[TBL] [Abstract][Full Text] [Related]
15. Red cell aplasia responsive to immunoglobulin therapy as initial manifestation of human immunodeficiency virus infection.
Gottlieb F; Deutsch J
Am J Med; 1992 Mar; 92(3):331-3. PubMed ID: 1546732
[TBL] [Abstract][Full Text] [Related]
16. Intravenous immunoglobulins in autoimmune- or parvovirus B19-mediated pure red-cell aplasia.
Mouthon L; Guillevin L; Tellier Z
Autoimmun Rev; 2005 Jun; 4(5):264-9. PubMed ID: 15990072
[TBL] [Abstract][Full Text] [Related]
17. Parvovirus infection and its treatment.
Young NS
Clin Exp Immunol; 1996 May; 104 Suppl 1():26-30. PubMed ID: 8625539
[TBL] [Abstract][Full Text] [Related]
18. Recurrent pure red cell aplasia in a hepatorenal transplant recipient with chronic parvovirus B19 infection.
Rivas-Delgado A; Matutes E; Rozman M
Br J Haematol; 2016 Feb; 172(4):495. PubMed ID: 26457576
[No Abstract] [Full Text] [Related]
19. Atraumatic splenic rupture following IVIg for parvovirus B19 pure red cell aplasia post renal transplant.
Tiong M; Casan J; McLean C
Transpl Infect Dis; 2019 Apr; 21(2):e13045. PubMed ID: 30586222
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulin therapy for pure red cell aplasia related to human parvovirus b19 infection: a retrospective study of 10 patients and review of the literature.
Crabol Y; Terrier B; Rozenberg F; Pestre V; Legendre C; Hermine O; Montagnier-Petrissans C; Guillevin L; Mouthon L;
Clin Infect Dis; 2013 Apr; 56(7):968-77. PubMed ID: 23243178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
